SCHEMBL11250252

SCHEMBL11250252

O=C(O)Cc1c(-c2ccccc2)nn(-c2ccccc2Cl)c1-c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 16/20 0.51
PTGDR2 Q9Y5Y4 3/20 0.49
CNR2 P34972 1/20 0.44
AKR1B1 P15121 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11242908 0.89 PTGDR2 (0.50) CNR1PTGDR2AKR1B1
SCHEMBL11255798 0.88 MARS1 (0.50) CNR1PTGDR2CNR2
Trifezolac SCHEMBL11182574 0.82 KDM4E (0.51) PTGDR2
SCHEMBL11255212 0.82 PTGDR2 (0.54) PTGDR2
SCHEMBL11261876 0.81 KDM4E (0.54) PTGDR2
SCHEMBL11699362 0.81 KDM4E (0.55) PTGDR2
SCHEMBL2679126 0.80 CNR1 (0.65) CNR1
SCHEMBL11254556 0.80 PTGDR2 (0.47) CNR1PTGDR2
SCHEMBL11243360 0.79 KDM4E (0.56) CNR1PTGDR2
SCHEMBL11698586 0.78 ALDH1A1 (0.43) CNR1CNR2AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4325962-A ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIDYRETICS BYK-GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1982-04-20 US claimed
US-4146721-A ANALGESICS, ANTIINFLAMMATORY AGENTS AND ANTIPYRETICS BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1979-03-27 US claimed
US-4325962-A ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIDYRETICS BYK-GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1982-04-20 US disclosed
US-4146721-A ANALGESICS, ANTIINFLAMMATORY AGENTS AND ANTIPYRETICS BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1979-03-27 US disclosed